Withdrawal Dilemma
The physician, meanwhile, depends on the information provided by medical science, usually in the form of materials from the pharma firm that markets the product.
Read More
Select Page
Posted by C. Scott McMillin | Jun 20, 2019 | Addiction Clinicians | 0 |
The physician, meanwhile, depends on the information provided by medical science, usually in the form of materials from the pharma firm that markets the product.
Read MorePosted by C. Scott McMillin | Jun 17, 2019 | Addictive Substances, Public Health | 0 |
The list of deaths from the practice is long and oddly prestigious, featuring celebs such as John Belushi and Chris Farley, among many others.
Read MorePosted by C. Scott McMillin | Jun 13, 2019 | People in Recovery | 0 |
The benefits needn’t be long-lasting, just readily accessible when you discover you need them.
Read MorePosted by C. Scott McMillin | Jun 10, 2019 | In the News, Public Policy | 0 |
Meanwhile , the healthcare field continues to struggle with legitimate issues around the use of (and controls over) opioids in medical practice.
Read MorePosted by C. Scott McMillin | Jun 6, 2019 | Addiction Clinicians, Addictive Substances | 0 |
If the dose is in fact subtherapeutic, then what causes the effects so enthusiastically reported by the user?
Read More